SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-17-002187
Filing Date
2017-03-06
Accepted
2017-03-06 07:02:15
Documents
4
Period of Report
2017-03-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp73540_8k.htm 8-K 20194
2 EXHIBIT 99.1 dp73540_ex9901.htm EX-99.1 12468
3 GRAPHIC image_001.jpg GRAPHIC 10054
4 GRAPHIC image_002.jpg GRAPHIC 10054
  Complete submission text file 0000950103-17-002187.txt   61953
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 17666462
SIC: 2834 Pharmaceutical Preparations